Phase 2 Trial Assesses c-Abl Inhibitor for Early Parkinson’s
In a landmark clinical advancement poised to reshape the therapeutic landscape of neurodegenerative disorders, researchers have unveiled compelling data on ...
In a landmark clinical advancement poised to reshape the therapeutic landscape of neurodegenerative disorders, researchers have unveiled compelling data on ...
Recent advancements in the field of medicinal chemistry have stirred a renewed interest in compounds that may revolutionize the treatment ...
In the ever-evolving landscape of biomedical research, targeted protein degradation has emerged as a promising frontier in therapeutic development. This ...
In a groundbreaking advance that could reshape therapeutic approaches for Alzheimer’s disease (AD), researchers have unveiled a detailed mechanism by ...
A groundbreaking study from the Institute for Basic Science (IBS) unveils a revolutionary, non-invasive technique to amplify the brain’s intrinsic ...
In a landmark study published on May 20, 2025, researchers from The Hebrew University of Jerusalem have unveiled an extraordinary ...
Bright Light Therapy Illuminates New Pathways for Parkinson’s Disease Treatment Parkinson’s disease (PD), a progressive neurodegenerative disorder marked by motor ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine